Rolan, P E <br/><br/>
The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers.  [electronic resource] 

 -  European journal of clinical pharmacology  1990 
 - 311-3 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0031-6970 
<br/><br/><label>Standard No.: </label>10.1007/BF00315119  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Bronchi--drug effects<br/>Double-Blind Method<br/>Female<br/>Histamine<br/>Histamine Antagonists--pharmacology<br/>Histamine H1 Antagonists--pharmacology<br/>Humans<br/>Male<br/>Maximal Expiratory Flow Rate--drug effects<br/>Triprolidine--analogs & derivatives